BioSpace News Archive

VISULAS® green, the next generation of photocoagulation laser from ZEISS allows doctors to fully concentrate on the patient’s treatment procedure without interruption.

SoPHiA GENETICS, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS).

Novartis announced 14-month results from the pivotal JULIET clinical trial showing ongoing durable responses are achievable with Kymriah® (tisagenlecleucel) when administered to adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

Dr. Reddy’s Laboratories Limited announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2018 was filed with the United States Securities and Exchange Commission on June 15, 2018.

Daiichi Sankyo Company, Limited announced that positive results from the pivotal QuANTUM-R phase 3 study of single agent quizartinib were presented today as a late-breaking oral presentation in the plenary program at the 23rd Congress of the European Hematology Association (EHA) in Stockholm, Sweden.

Campaign 2000 will release a report on Child Poverty by Ridings on Monday June 18, 2018.

Dr. Reddy’s Laboratories Ltd. announced that following the launch of its generic Buprenorphine and Naloxone Sublingual Film in the U.S. Market, the U.S. District Court for the District of New Jersey has received and reviewed an emergency application from the plaintiffs in the current patent litigation for a temporary restraining order and preliminary injunction against Dr. Reddy’s.

Verastem, Inc. announced one oral and three poster presentations at the 23rd Congress of the European Hematology Association (EHA)

risdiplam (RG7916) is well tolerated at all dose levels with no drug-related safety findings